1Binolfi A,Biasoli MS,Luque AG,et al.Hish prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina.Med Mycol,2005,43(5):431-437.
2Morgan J.Global trends in candidemia:review of reports from 1995-2005.Curt Infect Dis Rep,2005,7(6):429-439.
3Nisini R,Romagnoli G,Gomez MJ,et al.Antigenic properties and processing requirements of 65-kilodalton mannoprotein,a major antigen target of anti-Candida human T-cell response,as disclosed by specific human T-cell clones.Infect Immun,2001,69(6):3728-3736
4Toresantucci A,Bromuro C,Gomez MJ,et al.Identification of a 65 000 mannoprotein as a main target of human cell-mediated immune response to Candida albicans.J Infect Dis,1993,168(2):427-435.
5Hagensee M,Gallowey D.Growing human.papillomavius and virus-like particles in laboratory.Papillomavirus Rep,1993,4:121.124.
6Kennedy IM,Haddow JK,Clements JB.A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.J Virol,199l,65(4):2093-2097.
7Bremuro C,Torosantucci A,Gómez MJ,et al.Differential release of an immunodominant 65 000 mannoprotein antigen from yeast and mycelial forms of Candida albicans.J Med Vet Mycol,1994,32(6):447-459.
8Torosantucci A,Gomez MJ,Bromuro C,et al.Biochemical and antigenic characterization of marmoprotein constituents released from yeast and mycelial form of Candida albicans.J Med Vet Mycol,1991,29(6):361-372.
9La Valle R,Sandini S,Gomez MJ,et al.Generation of a recombinant 65-kilodalton mannopretein,a major antigen target of cell-mediated immune response to Candida albicans.Infect Immun,2000,68(12):6777-6784.
